Belgium: Rejuvenate Biomed, a biomedical company developing combination drugs for age-related diseases, has raised €15.7m (US$18.1m) in Series B funding led by Rejuveron Life Sciences and Vesalius Biocapital. Funds will…
Belgium: Rejuvenate Biomed, a biomedical company developing combination drugs for age-related diseases, has raised €15.7m (US$18.1m) in Series B funding led by Rejuveron Life Sciences and Vesalius Biocapital. Funds will…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


